Temperature-Responsive, Pluronic-g-poly(acrylic acid) Copolymers In Situ Gels for Ophthalmic Drug Delivery: Rheology, In Vitro Drug Release, and In Vivo Resident Property-Reference-Cited by-同舟云学术

Temperature-Responsive, Pluronic-g-poly(acrylic acid) Copolymers In Situ Gels for Ophthalmic Drug Delivery: Rheology, In Vitro Drug Release, and In Vivo Resident Property

Published:2008-01 Issue:3 Volume:34 Page:258-266
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Ma Wen-di,Xu Hui,Nie Shu-fang,Pan Wei-san

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1080/03639040701580622

Reference21 articles.

1. Controlled-Release Delivery System for the α-MSH Analog Melanotan-I Using Poloxamer 407

2. Novel Family of Thermogelling Materials via C−C Bonding between Poly(acrylic acid) and Poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide)

3. Properties of Aqueous Solutions and Gels of Poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide)-g-poly(acrylic acid)

4. Enhanced nasal retention of hydrophobically modified polyelectrolytes

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyacrylic acid-based drug delivery systems: A comprehensive review on the state-of-art;Journal of Drug Delivery Science and Technology;2022-12

2. ACACIA CATACHU GUM IN SITU FORMING GELS WITH PROLONGED RETENTION TIME FOR OCULAR DRUG DELIVERY;Asian Journal of Pharmaceutical and Clinical Research;2022-09-07

3. Glaucoma Treatment and Hydrogel: Current Insights and State of the Art;Gels;2022-08-17

4. Contemporary applications of thermogelling PEO-PPO-PEO triblock copolymers;Journal of Drug Delivery Science and Technology;2022-04

5. Optimization of the Micellar-Based In Situ Gelling Systems Posaconazole with Quality by Design (QbD) Approach and Characterization by In Vitro Studies;Pharmaceutics;2022-02-27